Viewing Study NCT03306394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2026-02-23 @ 8:06 PM
Study NCT ID: NCT03306394
Status: COMPLETED
Last Update Posted: 2024-07-25
First Post: 2017-08-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).
Sponsor: Institut de Recherches Internationales Servier
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic View
None colorectal View
None cancer View
None trifluridine/tipiracil View
None early access View